ISSN: 2319-9865
Bashaier Adam
Mohammed V University, Morocco
Posters & Accepted Abstracts: RRJMHS
Alzheimer’s disease (AD), the most common age-related neurodegenerative disorder (elderly people), is clinically characterized by progressive neuronal loss resulting in loss of memory and dementia. AD pathophysiology is degenerative disorder in the cerebral cortex, acetylcholine deficiency. The lesion begins at the level of the hippocampus (memory) and then gradually extend to the parietal cortex and then to the entire cortex. The objective of this work is to know the ways of management of Alzheimer’s disease. In fact, there is no cure for Alzheimer’s disease, so the chief goals of treatment are to maintain quality of life, maximize function in daily activities, enhance cognition, mood and behavior, foster a safe environment and promote social engagement, as appropriate. Key elements of a strategy to maximize dementia outcomes include regular monitoring of patient’s health and cognition, education and support to patients and their families, initiation of pharmacologic and nonpharmacologic treatments as appropriate, and evaluation of patient/family motivation to volunteer for a clinical trial.